Clearside Biomedical, Inc.
(NASDAQ:CLSD)
$0.85
-0.01 (-1.05%)
At Close: 4:00 PM
$0.86
0.01 (1.19%)
After Market: 2:23 AM
CLSD Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
CLSD Stock Price Today
Clearside Biomedical, Inc. (CLSD) stock declined over -1.05% intraday to trade at $0.85 a share on NASDAQ. The stock opened with a loss of -0.44% at $0.86 and touched an intraday high of $0.86, falling -1.05% against the last close of $0.86. The Clearside Biomedical, Inc. in stock market went to a low of $0.84 during the session.
CLSD Stock Snapshot
$0.86
Prev. Close
67.87 Million
Market Cap
$0.84
Day Low
$0.86
Open
61.17 Million
Number of Shares
$0.86
Day High
N/A
P/E ratio
-0.55
EPS (TTM)
0.56
Cash Flow per Share
0.52
Free Float in %
-0.08
Book Value
33496.00
Volume
CLSD Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
900 North Point ParkwayAlpharetta, GA 30005US
Website:https://www.clearsidebio.com
Contact #:678 270 3631
Company Information
Employees36.00
Beta2.09
Sales or Revenue$1.62 Million
5Y Sales Change30.90%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Peers
Frequently Asked Questions
What is the current Clearside Biomedical, Inc. (CLSD) stock price?
Clearside Biomedical, Inc. (NASDAQ: CLSD) stock price is $0.85 in the last trading session. During the trading session, CLSD stock reached the peak price of $0.86 while $0.84 was the lowest point it dropped to. The percentage change in CLSD stock occurred in the recent session was -1.05% while the dollar amount for the price change in CLSD stock was -$0.01.
CLSD's industry and sector of operation?
The NASDAQ listed CLSD is part of Biotechnology industry that operates in the broader Healthcare sector. Clearside Biomedical, Inc. , a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.
Who are the executives of CLSD?
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Pres, Chief Executive Officer & Director
Mr. Rick McElheny
Vice President of Corporation Devel.
Mr. Rafael V. Andino
Senior Vice President of Engineering & Manufacturing
Dr. Thomas A. Ciulla M.B.A., M.D.
Chief Medical Officer & Chief Devel. Officer
How CLSD did perform over past 52-week?
CLSD's closing price is 0.08% higher than its 52-week low of $0.825 where as its distance from 52-week high of $1.85 is -0.48%.
How many employees does CLSD have?
Number of CLSD employees currently stands at 36.00. CLSD operates from 900 North Point Parkway, Alpharetta, GA 30005, US.
Link for CLSD official website?
Official Website of CLSD is: https://www.clearsidebio.com
How do I contact CLSD?
CLSD could be contacted at phone #678 270 3631 and can also be accessed through its website. CLSD operates from 900 North Point Parkway, Alpharetta, GA 30005, US.
How many shares of CLSD are traded daily?
CLSD stock volume for the day was 33496.00 shares. The average number of CLSD shares traded daily for last 3 months was 184.46 Thousands.
What is the market cap of CLSD currently?
The market value of CLSD currently stands at $67.87 Million with its latest stock price at $0.85 and 61.17 Million of its shares outstanding.